All In Biotech

Drug Trial Radar · NCT00796263

Antiretroviral Therapy for Acute and Chronic HIV Infection

Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

900

Planned (sponsor's estimate)

Start

May 13, 2009

Primary completion

Jun 2033

Study completion Jun 2033

Sponsor

Lead sponsor
SEARCH Research FoundationAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
ViiV Healthcare
First posted
Nov 24, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose for this protocol is to provide safe and effective standard ART to SEARCH 010 and SEARCH 013 participants. Participants are enrolled in an acute HIV infection study (SEARCH 010 protocol: 'Establish and characterize an acute HIV infection cohort in a Thai high-risk population') or in a study of chronic HIV infection (SEARCH 013 protocol 'Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais').

Conditions

  • Acute HIV Infection
  • Chronic HIV Infection

Interventions

  • HAARTDrug

    1 (lamivudine) or 2 (lamivudine + abacavir) nuceloside/nucleotide analog reverse-transcriptase inhibitor (NRTI) class medications once daily plus dolutegravir(DTG) 50 mg orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HIV-related clinical eventsTime frame: 10 years
  2. Immunologic parameters including CD4 count and CD4/CD8 ratioTime frame: 10 years
  3. Virologic parameters including HIV RNA and HIV reservoir markersTime frame: 10 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institute of HIV Research and Innovation

    Bangkok, Thailand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.